VincentAMukkadaMD

Pediatric Gastroenterology • Cincinnati, OH

Pediatric Feeding and Swallowing Disorders, Pediatric Nutrition

Professor of Pediatrics, University of Cincinnati College of Medicine

Join to view full profile

Dr. Mukkada is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mukkada's full profile

Already have an account?

Office
3333 Burnet Ave
# ML2010
Cincinnati, OH 45229
Phone+1 513-636-4415

Fax+1 513-636-7805

Summary

Dr. Vincent Mukkada is a pediatric gastroenterologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 15 years. He specializes in pediatric feeding and swallowing disorders and pediatric nutrition and is experienced in eosinophilic gastrointestinal disease.

Education & Training

University of ColoradoFellowship, Pediatric Gastroenterology, 2005 - 2008
Brown UniversityResidency, Pediatrics, 2002 - 2005
University of Cincinnati College of MedicineClass of 2002

Certifications & Licensure

OH State Medical License 2012 - 2026
IN State Medical License 2022 - 2025
KY State Medical License 2021 - 2025
RI State Medical License 2004 - 2014
CO State Medical License 2006 - 2009
American Board of Pediatrics Pediatric Gastroenterology

Publications & Presentations

PubMed

Effect of Esophageal Dilation History on Efficacy Outcomes in Patients With Eosinophilic Esophagitis Receiving Budesonide Oral Suspension.
Ikuo Hirano, Margaret H Collins, David A Katzka, Vincent A Mukkada, Gary W Falk
The American Journal of Gastroenterology. 2024-11-12
Induction of sustained remission and reversal of pathologic transcriptome achieved with tezepelumab in an adolescent with eosinophilic esophagitis.
Colby S Sharlin, Margaret H Collins, Scott M Bolton, Garrett A Osswald, Ghassan S Safadi
The Journal of Allergy and Clinical Immunology. in Practice. 2024-11-01
T2 cell compensatory effect following benralizumab treatment for eosinophilic gastritis.
Netali Ben-Baruch Morgenstern, Yrina Rochman, Julie M Caldwell, Margaret H Collins, Vincent A Mukkada
The Journal of Allergy and Clinical Immunology. 2024-11-01

Press Mentions

Eosinophilic Esophagitis Risk Linked to Medications in Pregnancy, InfancyNovember 1st, 2023